Processa Pharmaceuticals (PCSA) Goodwill & Intangibles (2012 - 2022)

Processa Pharmaceuticals (PCSA) has 9 years of Goodwill & Intangibles data on file, last reported at $11.1 million in Q4 2022.

• Quarterly Goodwill & Intangibles rose 37.27% year-over-year to $11.1 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $11.1 million (up 37.27% YoY) and the FY2022 annual result came in at $11.1 million, up 37.27% from the prior year.
• Goodwill & Intangibles advanced to $11.1 million in Q4 2022, from $7.5 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $11.1 million in Q3 2018 to a low of $7.5 million in Q3 2022.
• A 5-year average of $9.3 million and a median of $9.2 million in 2020 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2019 — Goodwill & Intangibles slipped 11.01% — and 2022, when it jumped 37.27%.
• Tracing PCSA's Goodwill & Intangibles over 5 years: stood at $10.4 million in 2018, then retreated by 7.62% to $9.6 million in 2019, then retreated by 8.25% to $8.8 million in 2020, then declined by 8.93% to $8.1 million in 2021, then soared by 37.27% to $11.1 million in 2022.
• The last three Goodwill & Intangibles figures came in at $11.1 million (Q4 2022), $7.5 million (Q3 2022), and $7.7 million (Q2 2022), per Business Quant data.